Creatine and Creatinine Metabolism - Physiological Reviews

1206 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
869. SCHUMACHER G AND BUCKEL P. Stabile Creatinamidinohydrolase-Mutanten.
European Patent Application 0 291 055 A2, 1988.
870. SCHUMACHER G, BURTSCHER H, AND MOELLERING H. Cloned
N-methylhydantoinase. European Patent Application 0 464 832
A2, 1992.
871. SCHUMANN J, BÖHM G, SCHUMACHER G, RUDOLPH R, AND
JAENICKE R. Stabilization of creatinase from Pseudomonas
putida by random mutagenesis. Protein Sci 2: 1612–1620, 1993.
872. SCHUT HAJ AND SNYDERWINE EG. DNA adducts of heterocyclic
amine food mutagens: implications for mutagenesis and carcinogenesis.
Carcinogenesis 20: 353–368, 1999.
873. SCHWEIGER H, LÜTJEN-DRECOLL E, ARNOLD E, KOCH W,
NITSCHE R, AND BRAND K. Ischemia-induced alterations of mitochondrial
structure and function in brain, liver, and heart muscle
of young and senescent rats. Biochem Med Metab Biol 40:
162–185, 1988.
874. SEPPET EK, ADOYAAN AJ, KALLIKORM AP, CHERNOUSOVA
GB, LYULINA NV, SHAROV VG, SEVERIN VV, POPOVICH MI, AND
SAKS VA. Hormone regulation of cardiac energy metabolism. I.
Creatine transport across cell membranes of euthyroid and hyperthyroid
rat heart. Biochem Med 34: 267–279, 1985.
875. SEPPET EK AND SAKS VA. Thyroid hormones and the creatine
kinase system in cardiac cells. Mol Cell Biochem 133: 299–309,
1994.
876. SERAYDARIAN MW, ARTAZA L, AND ABBOTT BC. Creatine and
the control of energy metabolism in cardiac and skeletal muscle
cells in culture. J Mol Cell Cardiol 6: 405–413, 1974.
877. SHAINKIN-KESTENBAUM R, GIAT Y, AND BERLYNE GM. The
toxicity of guanidino compounds in the red blood cell in uremia
and the effects of hemodialysis. Nephron 31: 20–23, 1982.
878. SHAINKIN-KESTENBAUM R, WINIKOFF Y, DVILANSKY A,
CHAIMOVITZ C, AND NATHAN I. Effect of guanidino-propionic
acid on lymphocyte proliferation. Nephron 44: 295–298, 1987.
879. SHARKEY SW, ELSPERGER KJ, MURAKAMI M, AND APPLE FS.
Canine myocardial creatine kinase isoenzyme response to coronary
artery occlusion. Am J Physiol Heart Circ Physiol 256:
H508–H514, 1989.
880. SHARMA R, VENKATASUBRAMANIAN PN, BÁRÁNY M, AND
DAVIS JM. Proton magnetic resonance spectroscopy of the brain
in schizophrenic and affective patients. Schizophrenia Res 8:
43–49, 1992.
881. SHIKATA H, KOYAMA S-Y, EGI Y, YAMADA K, AND KAWASAKI T.
Identification of creatine as a cofactor of thiamin-diphosphate
kinase. FEBS Lett 201: 101–104, 1986.
882. SHIMAMOTO N, GOTO N, TANABE M, IMAMOTO T, FUJIWARA
S, AND HIRATA M. Myocardial energy metabolism in the hypertrophied
hearts of spontaneously hypertensive rats. Basic Res Cardiol
77: 359–371, 1982.
883. SHIMIZU S, KIM J-M, AND YAMADA H. Microbial enzymes for
creatinine assay: a review. Clin Chim Acta 185: 241–252, 1989.
884. SHIMIZU S, KIM JM, SHINMEN Y, AND YAMADA H. Evaluation of
two alternative metabolic pathways for creatinine degradation in
microorganisms. Arch Microbiol 145: 322–328, 1986.
885. SHIMIZU Y, MORIMOTO K, KURODA S, AND MORI A. Sustained
increase of methylguanidine in rats after amygdala or hippocampal
kindling. Epilepsy Res 21: 11–17, 1995.
886. SHIRAI T, SANO M, TAMANO S, TAKAHASHI S, HIROSE M,
FUTAKUCHI M, HASEGAWA R, IMAIDA K, MATSUMOTO K-I,
WAKABAYASHI K, SUGIMURA T, AND ITO N. The prostate: a
target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP) derived from cooked foods. Cancer
Res 57: 195–198, 1997.
887. SHOUBRIDGE EA, CHALLISS RAJ, HAYES DJ, AND RADDA GK.
Biochemical adaptation in the skeletal muscle of rats depleted of
creatine with the substrate analogue �-guanidinopropionic acid.
Biochem J 232: 125–131, 1985.
888. SHOUBRIDGE EA, JEFFRY FMH, KEOGH JM, RADDA GK, AND
SEYMOUR A-ML. Creatine kinase kinetics, ATP turnover, and
cardiac performance in hearts depleted of creatine with the substrate
analogue �-guanidinopropionic acid. Biochim Biophys
Acta 847: 25–32, 1985.
889. SHOUBRIDGE EA AND RADDA GK. A 31 P-nuclear magnetic resonance
study of skeletal muscle metabolism in rats depleted of
creatine with the analogue �-guanidinopropionic acid. Biochim
Biophys Acta 805: 79–88, 1984.
890. SHOUBRIDGE EA AND RADDA GK. A gated 31 P NMR study of
tetanic contraction in rat muscle depleted of phosphocreatine.
Am J Physiol Cell Physiol 252: C532–C542, 1987.
891. SHYU K-G, KUAN P-L, CHENG J-J, AND HUNG C-R. Cardiac troponin
T, creatine kinase, and its isoform release after successful
percutaneous transluminal coronary angioplasty with or without
stenting. Am Heart J 135: 862–867, 1998.
892. SIEDEL J, DEEG R, RÖDER A, ZIEGENHORN J, MÖLLERING H,
AND GAUHL H. Nucleosidtriphosphat-abhängige 1-Methylhydantoinase
und ihre Verwendung. Boehringer Mannheim Offenlegungsschrift
DE 3406770 A1, German Patent Office, 1985.
893. SIEDEL J, DEEG R, SEIDEL H, MÖLLERING H, STAEPELS J,
GAUHL H, AND ZIEGENHORN J. Fully enzymatic colorimetric
assay of serum and urine creatinine which obviates the need for
sample blank measurements. Anal Lett 21: 1009–1017, 1988.
894. SIEGEL RJ, SAID JW, SHELL WE, CORSON G, AND FISHBEIN MC.
Identification and localization of creatine kinase B and M in
normal, ischemic and necrotic myocardium. An immunohistochemical
study. J Mol Cell Cardiol 16: 95–103, 1984.
895. SIEVERS H AND MÜLLER E. Untersuchungen über den Stoffwechsel
des Bacillus Tetani. Z Biol 86: 527–534, 1927.
896. SINHA R, ROTHMAN N, BROWN ED, SALMON CP, KNIZE MG,
SWANSON CA, ROSSI SC, MARK SD, LEVANDER OA, AND FEL-
TON JS. High concentrations of the carcinogen 2-amino-1-methyl-
6-phenylimidazo[4,5-b]pyridine (PhIP) occur in chicken but are
dependent on the cooking method. Cancer Res 55: 4516–4519,
1995.
897. SIPILÄ I. Inhibition of arginine-glycine amidinotransferase by ornithine.
A possible mechanism for the muscular and chorioretinal
atrophies in gyrate atrophy of the choroid and retina with hyperornithinemia.
Biochim Biophys Acta 613: 79–84, 1980.
898. SIPILÄ I, RAPOLA J, SIMELL O, AND VANNAS A. Supplementary
creatine as a treatment for gyrate atrophy of the choroid and
retina. N Engl J Med 304: 867–870, 1981.
899. SIPILÄ I, SIMELL O, AND ARJOMAA P. Gyrate atrophy of the
choroid and retina with hyperornithinemia. Deficient formation of
guanidinoacetic acid from arginine. J Clin Invest 66: 684–687,
1980.
900. SIPILÄ I, SIMELL O, RAPOLA J, SAINIO K, AND TUUTERI L.
Gyrate atrophy of the choroid and retina with hyperornithinemia:
tubular aggregates and type 2 fiber atrophy in muscle. Neurology
29: 996–1005, 1979.
901. SIPILÄ I, VALLE D, AND BRUSILOW S. Low guanidinoacetic acid
and creatine concentrations in gyrate atrophy of the choroid and
retina (GA). In: Guanidino Compounds in Biology and Medicine,
edited by P. P. De Deyn, B. Marescau, V. Stalon, and I. A. Qureshi.
London: Libbey, 1992, p. 379–383.
902. SKOG K. Cooking procedures and food mutagens: a literature
review. Food Chem Toxicol 31: 655–675, 1993.
903. SKOG K, AUGUSTSSON K, STEINECK G, STENBERG M, AND
JÄGERSTAD M. Polar and non-polar heterocyclic amines in
cooked fish and meat products and their corresponding pan residues.
Food Chem Toxicol 35: 555–565, 1997.
904. SKOG K AND JÄGERSTAD M. Effects of monosaccharides and
disaccharides on the formation of food mutagens in model systems.
Mutat Res 230: 263–272, 1990.
905. SKOG K, KNIZE MG, FELTON JS, AND JÄGERSTAD M. Formation
of new heterocyclic amine mutagens by heating creatinine, alanine,
threonine and glucose. Mutat Res 268: 191–197, 1992.
906. SMEITINK J, STADHOUDERS A, SENGERS R, RUITENBEEK W,
WEVERS R, TER LAAK H, AND TRIJBELS F. Mitochondrial creatine
kinase containing crystals, creatine content and mitochondrial
creatine kinase activity in chronic progressive external ophthalmoplegia.
Neuromuscular Disorders 2: 35–40, 1992.
907. SMITH C, PAYNE V, DOOLITTLE DJ, DEBNATH AK, LAWLOR T,
AND HANSCH C. Mutagenic activity of a series of synthetic and
naturally occurring heterocyclic amines in Salmonella. Mutat Res
279: 61–73, 1992.
908. SMITH CD, CARNEY JM, STARKE-REED PE, OLIVER CN,
STADTMAN ER, FLOYD RA, AND MARKESBERY WR. Excess
brain protein oxidation and enzyme dysfunction in normal aging